Deuruxolitinib improves mental health in alopecia patients

hcplive.com

Deuruxolitinib significantly improves anxiety and depression in adults with severe alopecia areata. Pooled data from THRIVE-AA1 and THRIVE-AA2 trials showed patients on 8mg deuruxolitinib BID experienced greater reductions in anxiety and depression scores compared to placebo. Alopecia areata is an autoimmune condition linked to diminished quality of life and increased mental health issues.


With a significance score of 3.3, this news ranks in the top 7.3% of today's 22802 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Deuruxolitinib improves mental health in alopecia patients | News Minimalist